NK Cell Therapy Industry Research Report 2023

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,950	88 Pages	APO Research, Inc.	August, 2023	APRC18411446

Best Price Guarantee
Price	from $2,950
Length	88 Pages
Publisher	APO Research, Inc.
Published Date	August, 2023
SKU	APRC18411446

NK Cell Therapy Industry Research Report 2023

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

Highlights

The global NK Cell Therapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy.
The NK Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global NK Cell Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NK Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech

Product Type Insights

Global markets are presented by NK Cell Therapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the NK Cell Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
NK Cell Therapy segment by Type

NK Cell Therapies
NK Cell Directed Antibodies

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the NK Cell Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the NK Cell Therapy market.
NK Cell Therapy Segment by Application

Cancer
Gastrointestinal Diseases
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the NK Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of NK Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the NK Cell Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cell Therapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of NK Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?

1 Preface: 1.1 Scope of Report; 1.2 Reasons for Doing This Study; 1.3 Research Methodology; 1.4 Research Process; 1.5 Data Source; 1.5.1 Secondary Sources; 1.5.2 Primary Sources
2 Market Overview: 2.1 Product Definition; 2.2 NK Cell Therapy by Type; 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029); 1.2.2 NK Cell Therapies; 1.2.3 NK Cell Directed Antibodies; 2.3 NK Cell Therapy by Application; 2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029); 2.3.2 Cancer; 2.3.3 Gastrointestinal Diseases; 2.3.4 Others; 2.4 Assumptions and Limitations
3 NK Cell Therapy Breakdown Data by Type: 3.1 Global NK Cell Therapy Historic Market Size by Type (2018-2023); 3.2 Global NK Cell Therapy Forecasted Market Size by Type (2023-2028)
4 NK Cell Therapy Breakdown Data by Application: 4.1 Global NK Cell Therapy Historic Market Size by Application (2018-2023); 4.2 Global NK Cell Therapy Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends: 5.1 Global NK Cell Therapy Market Perspective (2018-2029); 5.2 Global NK Cell Therapy Growth Trends by Region; 5.2.1 Global NK Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029; 5.2.2 NK Cell Therapy Historic Market Size by Region (2018-2023); 5.2.3 NK Cell Therapy Forecasted Market Size by Region (2024-2029); 5.3 NK Cell Therapy Market Dynamics; 5.3.1 NK Cell Therapy Industry Trends; 5.3.2 NK Cell Therapy Market Drivers; 5.3.3 NK Cell Therapy Market Challenges; 5.3.4 NK Cell Therapy Market Restraints
6 Market Competitive Landscape by Players: 6.1 Global Top NK Cell Therapy Players by Revenue; 6.1.1 Global Top NK Cell Therapy Players by Revenue (2018-2023); 6.1.2 Global NK Cell Therapy Revenue Market Share by Players (2018-2023); 6.2 Global NK Cell Therapy Industry Players Ranking, 2021 VS 2022 VS 2023; 6.3 Global Key Players of NK Cell Therapy Head office and Area Served; 6.4 Global NK Cell Therapy Players, Product Type & Application; 6.5 Global NK Cell Therapy Players, Date of Enter into This Industry; 6.6 Global NK Cell Therapy Market CR5 and HHI; 6.7 Global Players Mergers & Acquisition
7 North America: 7.1 North America NK Cell Therapy Market Size (2018-2029); 7.2 North America NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029; 7.3 North America NK Cell Therapy Market Size by Country (2018-2023); 7.4 North America NK Cell Therapy Market Size by Country (2024-2029); 7.5 United States; 7.6 Canada
8 Europe: 8.1 Europe NK Cell Therapy Market Size (2018-2029); 8.2 Europe NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029; 8.3 Europe NK Cell Therapy Market Size by Country (2018-2023); 8.4 Europe NK Cell Therapy Market Size by Country (2024-2029); 7.4 Germany; 7.5 France; 7.6 U.K.; 7.7 Italy; 7.8 Russia; 7.9 Nordic Countries
9 Asia-Pacific: 9.1 Asia-Pacific NK Cell Therapy Market Size (2018-2029); 9.2 Asia-Pacific NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029; 9.3 Asia-Pacific NK Cell Therapy Market Size by Country (2018-2023); 9.4 Asia-Pacific NK Cell Therapy Market Size by Country (2024-2029); 8.4 China; 8.5 Japan; 8.6 South Korea; 8.7 Southeast Asia; 8.8 India; 8.9 Australia
10 Latin America: 10.1 Latin America NK Cell Therapy Market Size (2018-2029); 10.2 Latin America NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029; 10.3 Latin America NK Cell Therapy Market Size by Country (2018-2023); 10.4 Latin America NK Cell Therapy Market Size by Country (2024-2029); 9.4 Mexico; 9.5 Brazil
11 Middle East & Africa: 11.1 Middle East & Africa NK Cell Therapy Market Size (2018-2029); 11.2 Middle East & Africa NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029; 11.3 Middle East & Africa NK Cell Therapy Market Size by Country (2018-2023); 11.4 Middle East & Africa NK Cell Therapy Market Size by Country (2024-2029); 10.4 Turkey; 10.5 Saudi Arabia; 10.6 UAE
12 Players Profiled: 11.1 Nektar Therapeutics; 11.1.1 Nektar Therapeutics Company Detail; 11.1.2 Nektar Therapeutics Business Overview; 11.1.3 Nektar Therapeutics NK Cell Therapy Introduction; 11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2017-2022); 11.1.5 Nektar Therapeutics Recent Development; 11.2 Innate Pharma SA; 11.2.1 Innate Pharma SA Company Detail; 11.2.2 Innate Pharma SA Business Overview; 11.2.3 Innate Pharma SA NK Cell Therapy Introduction; 11.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2017-2022); 11.2.5 Innate Pharma SA Recent Development; 11.3 Affimed; 11.3.1 Affimed Company Detail; 11.3.2 Affimed Business Overview; 11.3.3 Affimed NK Cell Therapy Introduction; 11.3.4 Affimed Revenue in NK Cell Therapy Business (2017-2022); 11.3.5 Affimed Recent Development; 11.4 Chipscreen Biosciences; 11.4.1 Chipscreen Biosciences Company Detail; 11.4.2 Chipscreen Biosciences Business Overview; 11.4.3 Chipscreen Biosciences NK Cell Therapy Introduction; 11.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2017-2022); 11.4.5 Chipscreen Biosciences Recent Development; 11.5 Fate Therapeutics; 11.5.1 Fate Therapeutics Company Detail; 11.5.2 Fate Therapeutics Business Overview; 11.5.3 Fate Therapeutics NK Cell Therapy Introduction; 11.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2017-2022); 11.5.5 Fate Therapeutics Recent Development; 11.6 Glycostem Therapeutics; 11.6.1 Glycostem Therapeutics Company Detail; 11.6.2 Glycostem Therapeutics Business Overview; 11.6.3 Glycostem Therapeutics NK Cell Therapy Introduction; 11.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2017-2022); 11.6.5 Glycostem Therapeutics Recent Development; 11.7 Dragonfly Therapeutics; 11.7.1 Dragonfly Therapeutics Company Detail; 11.7.2 Dragonfly Therapeutics Business Overview; 11.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction; 11.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2017-2022); 11.7.5 Dragonfly Therapeutics Recent Development; 11.8 Kiadis Pharma; 11.8.1 Kiadis Pharma Company Detail; 11.8.2 Kiadis Pharma Business Overview; 11.8.3 Kiadis Pharma NK Cell Therapy Introduction; 11.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2017-2022); 11.8.5 Kiadis Pharma Recent Development; 11.9 NantWorks; 11.9.1 NantWorks Company Detail; 11.9.2 NantWorks Business Overview; 11.9.3 NantWorks NK Cell Therapy Introduction; 11.9.4 NantWorks Revenue in NK Cell Therapy Business (2017-2022); 11.9.5 NantWorks Recent Development; 11.10 Nkarta Therapeutics; 11.10.1 Nkarta Therapeutics Company Detail; 11.10.2 Nkarta Therapeutics Business Overview; 11.10.3 Nkarta Therapeutics NK Cell Therapy Introduction; 11.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2017-2022); 11.10.5 Nkarta Therapeutics Recent Development; 11.11 Fortress Biotech; 11.11.1 Fortress Biotech Company Detail; 11.11.2 Fortress Biotech Business Overview; 11.11.3 Fortress Biotech NK Cell Therapy Introduction; 11.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2017-2022); 11.11.5 Fortress Biotech Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables: Table 1. Secondary Sources; Table 2. Primary Sources; Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million); Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million); Table 5. Global NK Cell Therapy Market Size by Type (2018-2023) & (US$ Million); Table 6. Global NK Cell Therapy Revenue Market Share by Type (2018-2023); Table 7. Global NK Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million); Table 8. Global NK Cell Therapy Revenue Market Share by Type (2024-2029); Table 9. Global NK Cell Therapy Market Size by Application (2018-2023) & (US$ Million); Table 10. Global NK Cell Therapy Revenue Market Share by Application (2018-2023); Table 11. Global NK Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million); Table 12. Global NK Cell Therapy Revenue Market Share by Application (2024-2029); Table 13. Global NK Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029; Table 14. Global NK Cell Therapy Market Size by Region (2018-2023) & (US$ Million); Table 15. Global NK Cell Therapy Market Share by Region (2018-2023); Table 16. Global NK Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million); Table 17. Global NK Cell Therapy Market Share by Region (2024-2029); Table 18. NK Cell Therapy Market Trends; Table 19. NK Cell Therapy Market Drivers; Table 20. NK Cell Therapy Market Challenges; Table 21. NK Cell Therapy Market Restraints; Table 22. Global Top NK Cell Therapy Manufacturers by Revenue (US$ Million) & (2018-2023); Table 23. Global NK Cell Therapy Revenue Market Share by Manufacturers (2018-2023); Table 24. Global NK Cell Therapy Industry Manufacturers Ranking, 2021 VS 2022 VS 2023; Table 25. Global Key Players of NK Cell Therapy, Headquarters and Area Served; Table 26. Global NK Cell Therapy Manufacturers, Product Type & Application; Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI); Table 28. Global NK Cell Therapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022); Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans; Table 30. North America NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million); Table 31. North America NK Cell Therapy Market Size by Country (2018-2023) & (US$ Million); Table 32. North America NK Cell Therapy Market Size by Country (2024-2029) & (US$ Million); Table 33. Europe NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million); Table 34. Europe NK Cell Therapy Market Size by Country (2018-2023) & (US$ Million); Table 35. Europe NK Cell Therapy Market Size by Country (2024-2029) & (US$ Million); Table 36. Asia-Pacific NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million); Table 37. Asia-Pacific NK Cell Therapy Market Size by Country (2018-2023) & (US$ Million); Table 38. Asia-Pacific NK Cell Therapy Market Size by Country (2024-2029) & (US$ Million); Table 39. Latin America NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million); Table 40. Latin America NK Cell Therapy Market Size by Country (2018-2023) & (US$ Million); Table 41. Latin America NK Cell Therapy Market Size by Country (2024-2029) & (US$ Million); Table 42. Middle East & Africa NK Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million); Table 43. Middle East & Africa NK Cell Therapy Market Size by Country (2018-2023) & (US$ Million); Table 44. Middle East & Africa NK Cell Therapy Market Size by Country (2024-2029) & (US$ Million); Table 45. Nektar Therapeutics Company Detail; Table 46. Nektar Therapeutics Business Overview; Table 47. Nektar Therapeutics NK Cell Therapy Product; Table 48. Nektar Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 49. Nektar Therapeutics Recent Development; Table 50. Innate Pharma SA Company Detail; Table 51. Innate Pharma SA Business Overview; Table 52. Innate Pharma SA NK Cell Therapy Product; Table 53. Innate Pharma SA Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 54. Innate Pharma SA Recent Development; Table 55. Affimed Company Detail; Table 56. Affimed Business Overview; Table 57. Affimed NK Cell Therapy Product; Table 58. Affimed Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 59. Affimed Recent Development; Table 60. Chipscreen Biosciences Company Detail; Table 61. Chipscreen Biosciences Business Overview; Table 62. Chipscreen Biosciences NK Cell Therapy Product; Table 63. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 64. Chipscreen Biosciences Recent Development; Table 65. Fate Therapeutics Company Detail; Table 66. Fate Therapeutics Business Overview; Table 67. Fate Therapeutics NK Cell Therapy Product; Table 68. Fate Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 69. Fate Therapeutics Recent Development; Table 70. Glycostem Therapeutics Company Detail; Table 71. Glycostem Therapeutics Business Overview; Table 72. Glycostem Therapeutics NK Cell Therapy Product; Table 73. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 74. Glycostem Therapeutics Recent Development; Table 75. Dragonfly Therapeutics Company Detail; Table 76. Dragonfly Therapeutics Business Overview; Table 77. Dragonfly Therapeutics NK Cell Therapy Product; Table 78. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 79. Dragonfly Therapeutics Recent Development; Table 80. Kiadis Pharma Company Detail; Table 81. Kiadis Pharma Business Overview; Table 82. Kiadis Pharma NK Cell Therapy Product; Table 83. Kiadis Pharma Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 84. Kiadis Pharma Recent Development; Table 85. NantWorks Company Detail; Table 86. NantWorks Business Overview; Table 87. NantWorks NK Cell Therapy Product; Table 88. NantWorks Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 89. NantWorks Recent Development; Table 90. Nkarta Therapeutics Company Detail; Table 91. Nkarta Therapeutics Business Overview; Table 92. Nkarta Therapeutics NK Cell Therapy Product; Table 93. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 94. Nkarta Therapeutics Recent Development; Table 95. Fortress Biotech Company Detail; Table 96. Fortress Biotech Business Overview; Table 97. Fortress Biotech NK Cell TherapyProduct; Table 98. Fortress Biotech Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million); Table 99. Fortress Biotech Recent Development; Table 100. Nektar Therapeutics Company Information; Table 101. Nektar Therapeutics Business Overview; Table 102. Nektar Therapeutics NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 103. Nektar Therapeutics Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 104. Nektar Therapeutics Recent Development; Table 105. Innate Pharma SA Company Information; Table 106. Innate Pharma SA Business Overview; Table 107. Innate Pharma SA NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 108. Innate Pharma SA Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 109. Innate Pharma SA Recent Development; Table 110. Affimed Company Information; Table 111. Affimed Business Overview; Table 112. Affimed NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 113. Affimed Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 114. Affimed Recent Development; Table 115. Chipscreen Biosciences Company Information; Table 116. Chipscreen Biosciences Business Overview; Table 117. Chipscreen Biosciences NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 118. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 119. Chipscreen Biosciences Recent Development; Table 120. Fate Therapeutics Company Information; Table 121. Fate Therapeutics Business Overview; Table 122. Fate Therapeutics NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 123. Fate Therapeutics Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 124. Fate Therapeutics Recent Development; Table 125. Glycostem Therapeutics Company Information; Table 126. Glycostem Therapeutics Business Overview; Table 127. Glycostem Therapeutics NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 128. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 129. Glycostem Therapeutics Recent Development; Table 130. Dragonfly Therapeutics Company Information; Table 131. Dragonfly Therapeutics Business Overview; Table 132. Dragonfly Therapeutics NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 133. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 134. Dragonfly Therapeutics Recent Development; Table 135. Kiadis Pharma Company Information; Table 136. Kiadis Pharma Business Overview; Table 137. Kiadis Pharma NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 138. Kiadis Pharma Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 139. Kiadis Pharma Recent Development; Table 140. NantWorks Company Information; Table 141. NantWorks Business Overview; Table 142. NantWorks NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 143. NantWorks Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 144. NantWorks Recent Development; Table 145. Nkarta Therapeutics Company Information; Table 146. Nkarta Therapeutics Business Overview; Table 147. Nkarta Therapeutics NK Cell Therapy Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 148. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 149. Nkarta Therapeutics Recent Development; Table 150. Fortress Biotech Company Information; Table 151. Fortress Biotech Business Overview; Table 152. Fortress Biotech NK Cell TherapyRevenue in NK Cell Therapy Business (2018-2023) & (US$ Million); Table 153. Fortress Biotech Revenue in NK Cell Therapy Business (2018-2023) & (US$ Million) Portfolio; Table 154. Fortress Biotech Recent Development; Table 155. Authors List of This Report
List of Figures: Figure 1. Research Methodology; Figure 2. Research Process; Figure 3. Key Executives Interviewed; Figure 4. NK Cell Therapy Product Picture; Figure 5. Global NK Cell Therapy Market Size Comparison by Type (2023-2029) & (US$ Million); Figure 6. Global NK Cell Therapy Market Share by Type: 2022 VS 2029; Figure 7. NK Cell Therapies Product Picture; Figure 8. NK Cell Directed Antibodies Product Picture; Figure 9. Global NK Cell Therapy Market Size by Application (2023-2029) & (US$ Million); Figure 10. Global NK Cell Therapy Market Share by Application: 2022 VS 2029; Figure 11. Cancer Product Picture; Figure 12. Gastrointestinal Diseases Product Picture; Figure 13. Others Product Picture; Figure 14. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2029; Figure 15. Global NK Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029; Figure 16. Global NK Cell Therapy Market Share by Region: 2022 VS 2029; Figure 17. Global NK Cell Therapy Market Share by Players in 2022; Figure 18. Global NK Cell Therapy Players, Date of Enter into This Industry; Figure 19. Global Top 5 and 10 NK Cell Therapy Players Market Share by Revenue in 2022; Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022; Figure 21. North America NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 22. North America NK Cell Therapy Market Share by Country (2018-2029); Figure 23. United States NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 24. Canada NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 25. Europe NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 26. Europe NK Cell Therapy Market Share by Country (2018-2029); Figure 27. Germany NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 28. France NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 29. U.K. NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 30. Italy NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 31. Russia NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 32. Nordic Countries NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 33. Asia-Pacific NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 34. Asia-Pacific NK Cell Therapy Market Share by Country (2018-2029); Figure 35. China NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 36. Japan NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 37. South Korea NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 38. Southeast Asia NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 39. India NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 40. Australia NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 41. Latin America NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 42. Latin America NK Cell Therapy Market Share by Country (2018-2029); Figure 43. Mexico NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 44. Brazil NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 45. Middle East & Africa NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 46. Middle East & Africa NK Cell Therapy Market Share by Country (2018-2029); Figure 47. Turkey NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 48. Saudi Arabia NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 49. UAE NK Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million); Figure 50. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 51. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 52. Affimed Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 53. Chipscreen Biosciences Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 54. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 55. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 56. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 57. Kiadis Pharma Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 58. NantWorks Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 59. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2018-2023); Figure 60. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2018-2023)